Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rexam was a UK-based multinational packaging company best known for beverage cans and a broader portfolio spanning consumer and healthcare packaging. Historically, the company operated healthcare-related businesses including pharmaceutical packaging and drug-delivery device operations, but it was not a biotech, pharma, or therapeutics developer. Rexam was acquired by Ball in June 2016 and ceased to operate as an independent public company. Some former healthcare activities were also separated earlier, including the healthcare devices business that was renamed Nemera after its 2014 sale. For biotech analyst purposes, Rexam is best understood as a packaging and device-related industrial company with historical exposure to healthcare packaging rather than a life sciences innovator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rexam.